Last updated: 2026-10-13 09:24:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Penumbra, Inc. (PEN) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $320,87, with a market capitalization of $12,58B and a P/E ratio of 78,73. Over the past 52 weeks, its price has ranged from $221,26 to $362,41. This page covers its latest market performance, valuation, price trends and company information.
$12,58B | |
$319,91 | |
$362,41 | |
$35,32 | |
$319,40 | |
256,27K | |
348,53K | |
78,73 | |
$362,41 | |
$221,26 | |
-- | |
-- |
Penumbra, Inc. (PEN) is trading at $319,20 in pre-market trading as of 2026-10-12 23:31:00, down 0,06% ($0,20) from the previous close of $319,40
Pre-market trading shows how investors are pricing PEN before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, Penumbra, Inc. (PEN) moved from $317,55 to $320,87, representing a gain of 1,04% ($3,32).
The stock traded between $316,32 and $320,97 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 356,35 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 70,6%
PEN is currently trading at $320,87, placing it 70,6% of the way from its 52-week low of $221,26 to its 52-week high of $362,41. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 4700 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Penumbra, Inc. (PEN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.